Emergence of Proteus mirabilis carrying the blaVIM-1 metallo-β-lactamase gene

被引：35

作者：

Vourli, S.

Tsorlini, H.

Katsifa, H.

Polemis, M.

Tzouvelekis, L. S.

Kontodimou, A.

Vatopoulos, A. C.

机构：

[1] Natl Sch Publ Hlth, Dept Microbiol, Athens 11521, Greece

[2] Gen Hosp G Papanikolaou, Microbiol Lab, Thessaloniki, Greece

[3] Univ Athens, Sch Med, Dept Microbiol, GR-11527 Athens, Greece

来源：

CLINICAL MICROBIOLOGY AND INFECTION | 2006年 / 12卷 / 07期

关键词：

bla(VIM-1) gene; carbapenem resistance; integron; metallo-beta-lactamase; PCR mapping; Proteus mirabilis;

D O I：

10.1111/j.1469-0691.2006.01489.x

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Seven genetically related Proteus mirabilis clinical isolates from a hospital in Thessaloniki, Greece, exhibited decreased susceptibility to imipenem and carried a bla(VIM-1) metallo-beta-lactamase gene. PCR mapping revealed that bla(VIM-1) was part of a class 1 integron that was probably located in the chromosome and also included the aacA7, dhfr and aadA genes. This is the first description of the bla(VIM-1) metallo-beta-lactamase gene in P. mirabilis.

引用

收藏

页码：691 / 694

页数：5

相关论文

共 18 条

[1] Extended-spectrum β-lactamases in the 21st century:: Characterization, epidemiology, and detection of this important resistance threat [J].

Bradford, PA .

CLINICAL MICROBIOLOGY REVIEWS, 2001, 14 (04) :933-951

[2] Purification and biochemical characterization of the VIM-1 metallo-β-lactamase [J].

Franceschini, N ;

Caravelli, B ;

Docquier, JD ;

Galleni, M ;

Frère, JM ;

Amicosante, G ;

Rossolini, GM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (11) :3003-3007

[3] Characterization of a new integron containing blaVIM-1 and aac(6′)-IIc in an Enterobacter cloacae clinical isolate from Greece [J].

Galani, I ;

Souli, M ;

Chryssouli, Z ;

Orlandou, K ;

Giamarellou, H .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (05) :634-638

[4] Spread of integron-associated VIM-type metallo-β-lactamase genes among imipenem-nonsusceptible Pseudomonas aeruginosa strains in Greek hospitals [J].

Giakkoupi, P ;

Petrikkos, G ;

Tzouvelekis, LS ;

Tsonas, S ;

Legakis, NJ ;

Vatopoulos, AC .

JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (02) :822-825

[5] VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals [J].

Giakkoupi, P ;

Xanthaki, A ;

Kanelopoulou, M ;

Vlahaki, A ;

Miriagou, V ;

Kontou, S ;

Papafraggas, E ;

Malamou-Lada, H ;

Tzouvelekis, LS ;

Legakis, NJ ;

Vatopoulos, AC .

JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (08) :3893-3896

[6]

Goering RV, 1998, INFEC AGENT, P131

[7] Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-β-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. [J].

Lee, K ;

Lim, YS ;

Yong, D ;

Yum, JH ;

Chong, Y .

JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (10) :4623-4629

[8] PCR MAPPING OF INTEGRONS REVEALS SEVERAL NOVEL COMBINATIONS OF RESISTANCE GENES [J].

LEVESQUE, C ;

PICHE, L ;

LAROSE, C ;

ROY, PH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (01) :185-191

[9] Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-β-lactamase VIM-1 [J].

Miriagou, V ;

Tzelepi, E ;

Gianneli, D ;

Tzouvelekis, LS .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (01) :395-397

[10]

National Committee for Clinical Laboratory Standards (NCCLS), 2000, NCCLS document M2-A7, V7th